Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaccination with tumor RNA-loaded autologous dendritic cells versus observation in resected monosomy 3 uveal melanoma
DRKS00009784Phase 3Recruiting
- Sponsor
- Universitätsklinikum Erlangen
- Start
- Jan 2016
- Modality
- Dendritic Cell Vaccines → Immune Effector Cells → Other Cell Types → Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Autologous dendritic cells loaded with autologous tumor RNA in intraocular melanoma (2 arms), sponsored by Universitätsklinikum Erlangen. Started Jan 2016; status: recruiting.
02
Drugs
Autologous dendritic cells loaded with autologous tumor RNA
03
Conditions
intraocular melanoma
Beyond the preview
Go deeper on DRKS00009784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00009784.